Skip to main content
OpenTrials

Clinical trial condition

TDP-43 Proteinopathies

Explore clinical trials studying TDP-43 Proteinopathies. Study availability and eligibility vary by location and protocol.

870 public trials 211 recruiting studies

TDP-43 Proteinopathies trial results

Conditions
Aphasia, Aphasia, Primary Progressive, Brain Diseases, +22 more
Locations
  • The Ohio State University (OSU) Wexner Medical Center Columbus, Ohio, United States
  • Vanderbilt University Medical Centre Nashville, Tennessee, United States
  • Houston Methodist Hospital Houston, Texas, United States
  • UZ Leuven Leuven, Belgium
View all 19 locations
Conditions
Amyotrophic Lateral Sclerosis, Central Nervous System Diseases, Disease Attributes, +16 more
Locations
  • University of Alberta Edmonton, Alberta, Canada
  • University of Toronto / Sunnybrook Health Sciences Centre Toronto, Ontario, Canada
  • McGill University / Montreal Neurological Institute and Hospital Montreal, Quebec, Canada
  • CHU de Quebec -Universite de Laval Québec, Quebec, Canada

NCT03174938

Conditions
ALS (Amyotrophic Lateral Sclerosis), Alzheimer Disease, Amyotrophic Lateral Sclerosis, +55 more
Locations
  • Memory Clinic, Hospital of Ängelholm Ängelholm, Sweden
  • Memory Clinic, Skåne University Hospital Malmö, Sweden
Conditions
ALS (Amyotrophic Lateral Sclerosis), Amyotrophic Lateral Sclerosis, Brain Diseases, +22 more
Locations
  • Fondazione IRCCS Istituto Neurologico Carlo Besta Milan, Italy
  • Università degli Studi di Napoli "Federico II" Naples, Italy
  • Azienda Ospedaliero Universitaria di Sassari Sassari, Italy
  • Consorzio Interuniversitario Risonanze Magnetiche Metallo Proteine (CIRMMP) Sesto Fiorentino, Italy